Nontuberculous Mycobacterial Pulmonary Disease Clinical Trial
Official title:
A Prospective Registry for Nontuberculous Mycobacterial Pulmonary Disease
Background:
NTM(Nontuberculous mycobacteria) pulmonary disease is increasing worldwidely, however the
diagnosis and treatment of NTM pulmonary disease still has multiple obstacles. The initiation
of treatment is not necessary for all patients with NTM pulmonary disease. In addition, the
drugs for treatment of NTM pulmonary disease is not enough.
objective. The aim of this prospective registry for Nontuberculous mycobacterial pulmonary
disease is to register the NTM pulmonary patients and analysis of the treatment outcome based
on the species and to collect the blood and urine samples from the patients for exploring the
biomarker for diagnosis and monitoring the NTM pulmonary disease and collect the
nontuberculous mycobacterium.
Methods:
1. informed consents
2. register in cohort and collect the clinical information and serum, plasma, urine and
mycobacteria
3. follow up 6 months to 1year based on the clinical situation
Analysis:
1. treatment outcome based on NTM-NET consensus statement
2. exploration of biomarker for progression and monitoring of treatment response
n/a